Neratinib in HER2-Positive Breast Cancer With Brain Metastases. Dekker TJA. J Clin Oncol 2020 Dec 17:JCO2002385. doi: 10.1200/JCO.20.02385.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dekker TJA. Neratinib in HER2-Positive Breast Cancer With Brain Metastases. J Clin Oncol 2020 Dec 17:JCO2002385. doi: 10.1200/JCO.20.02385.
PMID: 33332187